On February 6, 2018 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") reported that it will release its fourth-quarter and full-year 2017 financial results on Wednesday, Feb. 28, 2018 (Press release, Valeant, FEB 6, 2018, http://ir.valeant.com/news-releases/2018/02-06-2018-152552266 [SID1234523770]). Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Call Details
Date:
Wednesday, Feb. 28, 2018
Time:
8:00 a.m. EST
Webcast:
http://ir.valeant.com/events-and-presentations
Participant Event Dial-in:
(844) 428-3520 (North America)
(409) 767-8386 (International)
Participant Passcode:
5287247
Replay Dial-in:
(855) 859-2056 (North America)
(404) 537-3406 (International)
Replay Passcode:
5287247 (replay available until Apr. 28, 2018)